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Innate immune interferons (IFNs), particularly type I IFNs, are primary mediators regulating
animal antiviral, antitumor, and cell-proliferative activity. These antiviral cytokines have
evolved remarkable molecular and functional diversity to confront ever-evolving viral
threats and physiological regulation. We have annotated IFN gene families across 110
animal genomes, and showed that IFN genes, after originating in jawed fishes, had
several significant evolutionary surges in vertebrate species of amphibians, bats and
ungulates, particularly pigs and cattle. For example, pigs have the largest but still
expanding type I IFN family consisting of nearly 60 IFN-coding genes that encode seven
IFN subtypes including multigene subtypes of IFN-α, -δ, and -ω. Whereas, subtypes such
as IFN-α and -β have been widely studied in many species, the unconventional subtypes
such as IFN-ω have barely been investigated. We have cross-species defined the IFN
evolution, and shown that unconventional IFN subtypes particularly the IFN-ω subtype
have evolved several novel features including: (1) being a signature multi-gene subtype
expanding primarily in mammals such as bats and ungulates, (2) emerging isoforms that
have superior antiviral potency than typical IFN-α, (3) highly cross-species antiviral (but
little anti-proliferative) activity exerted in cells of humans and other mammalian species,
and (4) demonstrating potential novel molecular and functional properties. This study
focused on IFN-ω to investigate the immunogenetic evolution and functional diversity
of unconventional IFN subtypes, which may further IFN-based novel antiviral design
pertinent to their cross-species high antiviral and novel activities.
Keywords: interferon, interferon-ω subtype, antiviral, molecular evolution, cytokine
INTRODUCTION
Innate immune interferons (IFNs), consisting of type I IFNs and type III IFNs, are key in regulating
antiviral immunity, antitumor activity, and cell proliferation (1–6). In contrast to the single type
II IFN (IFN-γ), which is primarily involved in adaptive immunity, type I IFNs are remarkable
for their molecular and functional diversity. However, to date only a few subtypes (e.g., IFN-α
and IFN-β) have been well characterized, even in humans and mice (1, 2, 4). Thus, there are
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significant knowledge gaps considering the evolutionarily
diversified 20–60 IFN-coding genes of multiple subtypes in
each mammalian species (2, 7–10). Interferon genes most likely
emerged during tetrapod evolution from fish (2, 10–12). The
common ancestor genes of IFNs were originally identified in
jawed fish, which almost coincides with the emergence of animal
adaptive immunity (2, 4). Fish only have a few ancestral intron-
containing IFN genes, but more than a dozen IFN genes in each
amniote species are mostly intronless (6–10, 12). The intronless
type I IFNs in amniotes appear to have arisen from a retroposition
event that is assumed to have replaced the original IFN locus by
integration of intron-spliced RNA and, thus, favored subsequent
gene duplication and family expansion adaptable to rapidly
evolving viruses and functional divergence (8–11). We have
examined IFN genes across the genome sequences of 120 animal
species, and we specifically characterized the emergence and
expansion of intronless IFNs in amphibians (10). In mammals,
intronless type I IFNs have evolved through a subtype expansion
resulting in at least nine subtypes, which include IFN-α, IFN-β,
IFN-ε, IFN-κ, and IFN-ω commonly found in most mammalian
species as well as IFN-δ (pigs), IFN-ζ (mice), and IFN-τ (cattle)
only detected in some species. Moreover, subtypes including
IFN-α, IFN-ω, IFN-δ, IFN-ζ, and IFN-τ have further diversified
into multi-gene sub-clusters (7–12).
Pigs (and cattle) have the largest expansion of type I IFNs
regarding subtypes and total IFN-coding gene numbers (8, 9).
For example, porcine type I IFN gene loci contain 57 predictable
IFN-coding genes (and 16 pseudogenes) spanning a nearly 1Mbp
genomic region and encoding at least 39 distinct IFN peptides
assigned to 17 IFN-αs, 11 IFN-δs, 7 IFN-ωs, plus one each of
IFN-β, IFN-ε, IFN-κ, and IFN-αω subtypes (9). Single IFN-ω-
like genes are identified in reptiles and birds, and multi-gene
IFN-ω subtypes are present in most ungulate and bat species.
Through phylogenic analysis we showed that porcine IFN-ωs are
orthologous to the majority of IFN-ω gene products identified so
far in different species (9, 13). This further indicates porcine IFN-
ω as a model to analyze functional novelty of this unconventional
IFN subtype. Comparative genomic studies show that pigs have a
molecular expansion of type I IFNs including IFN-ω genes, which
are several-fold more than those in mice or humans (9, 13).
Whereas, subtypes such as IFN-α and IFN-β have been widely
studied, the unconventional subtypes have been less investigated.
In this study, we have determined IFN gene evolution across 120
animal genomes that are available in current genome resources,
and shown evolutionary significance and gene expansion of
IFN genes in several representative species of amphibians, bats,
and ungulates. Further using the porcine and bovine IFN
complexes as a model, we have determined the molecular and
functional diversity of the evolving IFN subtypes, particularly
the less-studied unconventional IFN-ω subtype, which is an
IFN subtype emerging after reptiles and expanding in bats and
ungulates (7–15).
Expansion of the IFN complex and IFN-ω diversity in bats
and ungulates represent signature events of type I IFN evolution
(7–15). We hypothesize that this subtype-expansion confers
functional diversification that is necessary in regulating immune
responses against species-specific and even cross-species viral
infections (2, 7–15). Focusing on the IFN-ω members and
their antiviral and inflammatory regulation, we characterized
family-wide porcine innate immune IFNs for their functional
spectrum and therapeutic potential (9, 10, 13, 14), which was
profiled against two RNA viruses: porcine reproductive and
respiratory syndrome virus (PRRSV), and influenza A virus.
Both viruses have a high impact on the swine industry and
influenza A virus in swine, also threatens public health (13,
16). Here, we show that vertebrate IFN-ω subtype has evolved
several novel features, which include: (1) being a signature
multi-gene subtype expanding particularly in bats and ungulates
(7, 9, 17, 18), (2) emerging isoforms that have much higher
antiviral potency than typical IFN-α (14, 18, 19), (3) highly cross-
species antiviral (but little anti-proliferative) activity exerted in
cells of humans and other mammalian species (20), and (4)
other potential novel molecular and functional properties (3, 4,
18, 20). These observations suggest that animal unconventional
IFN subtypes have diversified their molecular composition
to extend functional spectrum particularly in antiviral and
immunomodulatory regulation (1–11).
MATERIALS AND METHODS
Ethics Statement, Animal Tissues,
and Cells
Porcine tissues and primary cells used for gene expression and
activity assays were cryopreserved samples from a previous study
(9). The Institutional Biosafety and Institutional Animal Care
andUse (IBC and IACUC) committees approved all recombinant
DNA procedures and animal procedures, respectively. Samples
of various tissues were collected, immediately snap frozen and
stored in liquid nitrogen until used for nucleic acid or protein
extraction (9, 13, 21).
Blood (∼20 ml/pig) was collected by jugular venipuncture
from anesthetized pigs. Immediately after euthanasia, cubes of
∼0.5 cm3 were dissected from lung or other indicated tissues
(9, 21, 22). Lungs were lavaged with 300 ml/each of 10mM PBS
(pH 7.4) (9, 13). Samples were placed on ice and peripheral
blood mononuclear cells (PBMCs) and macrophages (Mφs)
were isolated from the heparinized blood samples and lavage
fluids, respectively, within 4 h after collection. PBMCs were
isolated using a 60% Ficoll-Paque Plus gradient (GE Healthcare,
Piscataway, NJ). Monocytes were isolated from the PBMCs with
an anti-CD14 antibody (Ab), then the CD14− population was
used to isolate cDCs with a CD172 antibody (9, 13, 22), using
magnetic beads conjugated with the corresponding secondary Ab
(Miltenyi Biotec, Auburn, CA). The PRRSV-permissive mDCs
were generated by culturing monocytes in the presence of IL-4
and GM-CSF for 7 days as described (9, 13, 22). Lavage fluid was
centrifuged at 400× g for 15min to collect cells and further isolate
Mφs by plastic adherence (9, 22). Cells were used immediately
or cryopreserved in RecoveryTM cell culture freezing medium
(Invitrogen, Carlsbad, CA).
Cell lines used for cell proliferation and antiviral assays
were purchased from ATCC or transferred from collaborators
at Kansas State University. Cells were cultured following
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ATCC’s instruction or as previously described (10, 13). Cell
lines used include porcine testis cells (ST, ATCC R© CRL-
1746TM), porcine kidney cells (PK15, ATCC R© CCL-33TM),
human intestinal epithelial cells (A549, ATCC R© CRM-CCL-
185TM), mouse fibroblast cells (NIH/3T3, ATCC R© CRL-1658TM),
mouse kidney cells (Mode-K), and the monkey kidney cells
(MARC-145) (10, 13).
Bioinformatics and Phylogenetic
Procedures for Sequence Analyses
A combinative procedure was used to identify IFN genes
(including both predictable IFN-coding genes and pseudogenes)
in animal genomes (9, 10, 13). Single and grouped sequences,
or hidden Markov model (HMM) profiles generated using
sequence alignments with identified IFN peptide sequences in
fish, birds, mammals, and amphibians, were used to query
of genome assemblies available mainly through NCBI (http://
www.ncbi.nlm.nih.gov/genome/80, and Ensembl (http://useast.
ensembl.org/index.html), and sometimes through a species-
concentrated database such as at Xenbase (http://www.xenbase.
org/). Protein BLAST searches were conducted using the default
algorithm parameters with BLOSUM62 matrix and Expected
thresholds (E) <10 or 1. Resultant IFN homologs in each
species were further used as query entries to inspect other
more diversified IFN homologs in that species, which may
generally have less pairwise identity (<40%) to cross-species
IFN homologs.
The IFN genes were predicted and extracted from genomic
sequences, which span the regions having translated frames
significantly similar (∼50% peptide similarity and E <
10−5) to identified IFN sequences or consensuses. Programs
interactively used for gene prediction include GenomeScan
(http://hollywood.mit.edu/GENSCAN.html) and FGENESH
(http://www.softberry.com), and were further manually
annotated for confirmation. Peptide sequences were translated
using the translate tool at the ExPASy port, and signal
peptides were examined using PrediSi (http://www.predisi.
de). Sequence alignments were generated primarily using the
programs MUSCLE and ClustalW through EMBL-EBI port
(http://www.ebi.ac.uk/), and other sequence management was
conducted using programs at the Sequence Manipulation Suite
(http://www.bioinformatics.org). Visualization of sequence
alignments was conducted using Jalview, phylogenetic
analyses using MEGA6, recombination analyses using
SDT and RDP4, and topological comparison between the
Newick trees was performed with Compare2Trees (http://
www.mas.ncl.ac.uk/~ntmwn/compare2trees/). Other than
indicated, all programs were run with default parameters
(9, 10, 13).
Gene Identification, Expression Analyses,
and Cloning
Based on sequence analyses, we designed subtype-common or
gene-specific primers for expression analyses using quantitative
RT-PCR and cloning of coding regions from cDNA pools
(Supplementary Material for primer sequence) (9, 13). For
validation of the expression of various porcine IFNs, we
amplified cDNA covering whole coding ORFs of representative
genes in each gene or subgroup, cloned them in a pcDNA3.3
Topo-mammalian expression vector (Invitrogen, Carlsbad, CA),
and confirmed them by sequencing. The cDNA was reverse
transcribed from total RNA pools extracted from different
tissues with a SuperScript III first-strand synthesis system and
random primers (Invitrogen). Coding regions of IFNs were
amplified from this cDNA pool for transcription confirmation
and building expression constructs. Classification of porcine
IFN stimulated genes (ISGs) into tunable or robust subgroups
was referred to human or mouse ISGs, and gene-specific
primers were designed and validated using porcine gene
annotation (Supplemental Excel Sheet). PCR optimization, and
real-time RT-PCR analysis were performed as described (9,
10, 13). In brief, gene-specific or subtype-common primers
were designed based on multiple alignments of related IFN
sequences, and PCR conditions were optimized and validated
using confirmed IFN plasmids to show specific amplification
only with templates containing confirmed IFN clone(s). RNA
was extracted from tissues and cells as described above. Real-
time RT-PCR assays were conducted in a 96-well microplate
format using a StepOnePlusTM Real-Time PCR System (Applied
Biosystems, Grand Island, NY) with the validated primers.
Reactions were conducted with a SYBR Green RT-PCR system
(Qiagen, Valencia, CA) with 100 ng of total RNA in a 20-
µl reaction mixture. Specific optic detection was set at 78◦C
for 15 s after each amplification cycle of 95◦C for 15 s, 56–
59◦C for 30 s, and 72◦C for 40 s. Critical threshold (Ct)
values and melt curves were monitored and collected with
the real-time PCR system. Relative gene expression was first
normalized against Ct values of the housekeeping gene (β-
actin) for relative expression levels, and compared with the
expression levels of control samples for stimulated regulation
(9, 10, 13).
Viruses
All experiments using infectious viruses were conducted in the
laboratories with licenses and handled according to restrictive
regulations specified. Viruses used in this study tested include a
PRRSV P129 strain, and influenza A virus strains including 2009
pandemic H1N1 A/CA/04/09 (pH1N1), H1N1A/WSN/1933
(WSN), and H1N1A/swine/Kansas/77778/2007 (KS07). All
experiments using infectious agents were conducted in
the laboratories covered by effective licenses and handled
according to restrictive regulations specified. Viruses tested
include a PRRSV P129 strain, and influenza strains of
A/(H1N1)/pdm09 (pH1N1), A(H1N1)/WSN/1933(WSN),
and A(H1N1)/swine/Kansas/77778/2007(KS07). Procedures for
viral infections were conducted in cells as previously described
(9, 10, 13). Cytopathic effect (CPE) and immunochemical
staining of viruses were used to measure viral infectivity
and titers.
Antiviral Activity
IFN peptides were expressed using two eukaryotic systems,
a HEK293-mammalian expression system (Invitrogen) and a
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yeast expression system through collaboration with Kingfisher
Biotech (St. Paul, MN). The molecular authenticity of IFN
peptides expressed by both systems was verified with the
following aspects: (1) gene sequences; (2) protein band pattern
on protein gels; and (3) potential antiviral function tested in
different cell-virus systems. It is noteworthy that IFN peptides
expressed by both systems have been comparatively determined
multiple times to demonstrate the duplicity as shown in
several publications (9, 13, 14, 23, 24). The antiviral activity
of IFN peptides was tested on the cell/virus systems including:
MARC-145/PRRSV, porcine M8/PRRSV, A549/pH1N1, PK-
15/pH1N1, Mode-K/WSN, NIH3T3/WSN, Mode-K/KS07, and
NIH3T3/KS07, respectively. Briefly, cells were seeded in flat-
bottom 96-well plates and grown to >95% confluence. Cells
were infected with PRRSV or influenza viruses as indicated,
and treated with 1:10 serially diluted IFN peptides at 20–2
× 10−10 ng/ml. Viral infection was determined by staining
the cytopathic effect on cell monolayer with 1% crystal violet
or immuno-staining of the viruses, and quantified with a
SpectraMax i3 (Molecular Devices) spectrometer. Antiviral
activity of IFNs was calculated using the Reed–Muench Method
to normalize TCID50 and expressed as U/µg/ml. One unit
(U) is the highest dilution that reduced cell number by
50% (9, 10, 13).
Acidic and Thermal Stability
Interferon peptides were incubated at pH 2 for 24 h
at 4◦C, or at 42, 56, or 63◦C for 5 h, as described
previously (25), and the remaining antiviral activities of
the treated and untreated samples were then compared
using the MARC-145/PRRSV system as described above
(9, 10, 13).
Bioassays and ELISA
IFN bioassays were conducted in MARC-145 cells stably
transformed with IRF3-, IRF7-, or Mx1-promoter driven
luciferase reporter systems (9, 13, 22). In brief, for
bioassays, MARC-145 (IRF3, IRF7, or Mx1) cells were
treated with IFN peptides at indicated concentrations
for 24 h, lysed with Glo lysis buffer and quantified
by Steady-Glo
R©
Luciferase Assay System (Promega)
(13, 23).
Anti-proliferative Activity Assay
Cellular viability was assessed by trypan blue dye exclusion
(Invitrogen, Carlsbad, CA). Five-hundred cells in 100 µL
volume were added to each well of a flat-bottom 96-well plate
in triplicate. Cells were treated with or without IFN peptides
at the indicated concentrations (1:10 serially diluted from
2 ng/ml) and incubated at 37◦C for 72 h. Cell growth was
determined by a MTS-salt [3-(4,5-dimethythiazol-2-yl)]-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)
assay (Promega, Madison, WI). Briefly, 20 µl of MTS reagent
were added to each well and the plate incubated for 2–
4 h at 37◦C. Following color development, absorbance was
measured at 490 nm on a SpectraMax i3 (Molecular Devices)
spectrometer (23, 26).
Statistical Analysis
All statistical analyses were performed using Student’s t-test. Data
are presented asmean± SEM. A p value of< 0.05 was considered
statistically significant (9, 10, 13, 23).
RESULTS
Cross-Species IFN Gene Annotation and
Evolutionary Determination
Innate immune IFNs most likely emerged during tetrapod
evolution from fish (2, 5, 9, 10, 12). Cross-species genome-wide
annotation verified that fish only have a few ancestral intron-
containing IFNs; however, multiple IFN genes in each amniote
species are mostly intronless (2, 5, 9–12). The intronless type
I IFNs in amniotes appear to have arisen from a retroposition
event that is assumed to have replaced the original IFN locus
by the integration of intron-spliced RNA and, thus, favored
subsequent gene duplication and family expansion adaptable
to rapidly evolving viruses and functional divergence (2, 9–
12). We have genome-wide examined IFN genes across the
genome sequences of nearly 120 representative species of
vertebrates, and identified the emergence and expansion of
intronless IFNs in amphibians (10–12). For example, in two
Xenopus genomes, 13–16 intron-containing IFN genes (of both
type I and type III IFNs) exist that retain intron-containing
gene structure as fish IFN genes, and 24–37 intronless IFN
genes, indicating the emergence and expansion of intronless
IFN genes in amphibians rather than in reptiles as previously
assumed (Figure 1 and Supplemental Excel Sheet) (10–12).
Although type I IFN genes kept evolving to be intronless
in reptiles and birds, the gene diversification process became
less active than in amphibians, as most reptile and bird
species contain several IFN genes similar to those in the fish
but they are mostly, or nearly intronless (2, 10–12). Among
the analyzed bird species, the domestic chicken and duck
have the most 9–10 IFN-coding genes. Dramatic IFN gene
diversification further occurred in several mammalian species.
With regard to IFN-coding genes, ungulate species such as
cattle (Bos taurus/indicus) and pigs (Sus scrofa) have nearly 60
predictable IFN-coding genes as well as more than a dozen
pseudogenes (8, 9, 12). Other mammalian species show IFN
gene expansion with more than 20 predictable IFN-coding
genes including the ungulates domestic sheep, horses, and
yak, the house mouse and many primate species including
human and pongo (7). Most other wild mammalian species
generally have 7–16 predictable IFN-coding genes, except two
underground-living mole rats (H. glaber and F. damarensis)
that have most redundant compositions of type I IFN coding
genes comparable to fish. In summary, cross-species and
genome-wide definition of IFN genes in vertebrate species
determined previously unknown molecular complexity of IFN
expansion in Amphibian (10), Chiroptera, Rodent (except the
two moles) and domestic ungulate species especially pigs and
cattle (2, 8–10). This revises the linear-increasing pattern of
IFN molecular evolution as previously proposed along amniotic
evolution (12). Several gene expanding-surges are particularly
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FIGURE 1 | Molecular evolution and diversification of type I IFNs and IFN-ω subtype in representative vertebrate species. Functional IFN gene numbers are annotated
from released genomes of representative species and plotted along the phylogenetic order according to NCBI Taxonomy at http://www.ncbi.nlm.nih.gov/Taxonomy.
Several major events including the retroposition leading to emergence of intronless IFNs in amphibians, and expansion of IFNs in amphibians, livestock, bats, and
mice are shown (8–10).
evident in amphibians, domestic birds and ungulates, as well as
some rodent species, which illustrates a lineage, even species-
independent “bouncing model” with multiple peaks rather
than the previous linear-increase-model accompanying amniotic
evolution (Figure 1) (2, 10, 12).
The Specification of IFN-ω Subtype During
the Evolution of IFN Subtypes
The archetypal subtypes of type I IFNs in mammals such
as IFN-β, -ε, and –κ, appear ramified in reptiles, and
IFN-α and –ω subtypes were remarkable in birds with
some ambiguous progenitors detected in reptiles, as well
(Supplemental Excel Sheet 2) (2, 12). In contrast, the gene
composition of type III IFNs (i.e., IFN-λs) was ramified and
expanded in amphibians; however it was reduced dramatically
in reptiles and birds (generally only one IFN-λ gene) and
remained relatively stable (generally 3–5) in differentmammalian
clades/species (5, 9). In addition, typical intronless IFN-λ
genes were only determined in amphibian species, and rarely
determined in mammalian species except a bat species (Myotis
brandtii) (Supplemental Excel Sheet 2 and Data not shown).
All typical subtypes of type I IFNs were diversified in different
clades of mammalian species. In mammals, intronless type I IFNs
have evolved through a subtype expansion resulting in at least
nine subtypes, which include IFN-α, IFN-β, IFN-ε, IFN-κ, and
IFN-ω commonly found in most mammalian species as well as
IFN-δ (pigs), IFN-ζ (mice), IFN-τ (cattle), and IFN-αω (or –µ)
(pigs, horses, and cattle) only detected in some species (7–9, 27).
Moreover, subtypes including IFN-α, IFN-ω, IFN-δ, IFN-ζ, and
IFN-τ have further diversified into multi-gene sub-clusters (7–
9, 27). In terms of subtypes and total functional gene numbers,
pigs (and cattle) have the largest expansion of type I IFNs (7–9)
(Figure 1). For example, porcine type I IFN gene loci contain 57
predictable IFN-coding genes (and 16 pseudogenes) spanning a
nearly 1 Mbp genomic region and encoding at least 39 distinct
IFN peptides assigned to 17 IFN-αs, 11 IFN-δs, 7 IFN-ωs, plus
one each of IFN-β, IFN-ε, IFN-κ, and IFN-αω subtypes (7–9, 13).
Cross-species examination of IFN-ω genes indicated that
single IFN-ω-like genes are identified in reptiles and birds,
and multi-gene IFN-ω subtype are present in most ungulate
and bat species (Figures 1, 2, and Supplemental Excel Sheet).
Through phylogenic analysis, we showed that different species
of ungulates particularly domestic species such as cattle and pigs
experienced individual IFN-ω expansion because IFN-ω genes of
each species generally forming into one or two major expanding
clusters (2, 8, 9). Compared to generally one to several IFN-ω
genes in other species, cattle and pigs may have 11–25 IFN-ω
coding genes as well as about a dozen pseudogenes (Figure 2)
(8, 9). Porcine IFN-ω isoforms are orthologous to most, if not
all, IFN-ω gene products identified in mammalian species and
particularly the complex in cattle (7–9, 17, 18, 27). This further
identifies porcine IFN-ω as a model to analyze functional novelty
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FIGURE 2 | Evolutionary relationships of the IFN-ω orthologs in different animal species/lineage, and comparison with homologs from zebrafish (DrIFNs), Xenopus
(XtIFNs), chicken (GgIFNs), and humans (HsIFNs). The evolutionary history was inferred using the Neighbor-Joining method. Percentage of replicate trees in which the
(Continued)
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FIGURE 2 | associated taxa clustered together in the bootstrap test (1,000 replicates) is shown next to the branches. The tree is drawn to scale, with branch lengths
in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances were computed using the p-distance method
and are in units of the number of amino acid differences per site. Evolutionary analyses were conducted in MEGA6. The IFN-ω subtype diversified at the similar time of
IFN-α, IFN-β, or IFN-ε subtypes for the IFN ancestral molecules identified in jawed fish, but independently evolve further particularly in different mammalian
lineage/species. Most, if not all, IFN-ω orthologs form into a big cluster that further bifurcate into two subclusters (labeled with red dots), and the subcluster 1
comprises a majority of IFN-ω orthologs. IFN taxa used: IFNA, IFNB, IFNE, IFNK, IFNL, and IFNW correspond to genes for IFN-α, IFN-β, IFN-ε, IFN-κ, IFN-λ, and
IFN-ω, respectively, in classic nomenclature, and stand for relevant IFN protein precursors here (2, 8–10).
of this unconventional IFN subtype (Figures 1, 2) (7–9, 13).
Thus, comparative genomic studies show that pigs and cattle are
excellent examples demonstrating a molecular expansion of type
I IFNs including IFN-ω genes, which are several-fold more than
those in mice or humans (Figures 1, 2) (7–9, 17, 18, 27).
Genetic Polymorphisms of IFN-ω Genes
Genetic polymorphisms of a few nucleotide residues are
frequently found in the promoter or coding regions of type I
IFN genes (14, 28, 29). We and others have found that striking
differences in IFN activity is associated with simple polymorphic
mutations (14, 28, 29). This implies a genomic mechanism of
IFN-system evolution, which is critical in the arms race with ever-
mutating viruses to create a novel antiviral genotype. Regarding
porcine IFN-ω genes, on the basis of the 11 porcine IFN-ω
coding genes determined in the reference swine genome assembly
(Sscrofa11.1, NCBI), extensive sequencing of IFN genes isolated
from the DNA pool of 400 pig blood samples allowed us to
identify 3–7 SNP of each IFN-ω functional gene, with the IFN-ω5
gene having the maximal 7 SNP identified in that DNA pool (14).
These several porcine IFN-ω5 polymorphic isoforms (Figure 3),
which only differ from each other by few residues, showed
dramatic activity differences (Figures 6-9; next) (9, 13, 14, 24).
Subgroups of Vertebrate IFN-ω Peptides
Figure 4 shows pairwise identity (%) plots among protein
sequences of all identified IFN-ω orthologs across genome
sequences of about 60 representative vertebrate species (Figure 4,
upper panel, and Supplemental Excel Sheet) and the expanding
IFN-ω paralogs in swine and bovine species (Figure 4,
bottom panel, and Supplemental Excel Sheet) (7–9, 17, 18, 27).
Generally, we detected segregation of IFN-ω subtype in birds,
but the definitive formation of multi-gene IFN-ω was detected
in the genomes of mammals from all Orders except Monotremes,
Marsupials, and Rodents. Further phylogenic analysis indicated
that IFN-ω molecules from individual Order or Genus might
share one common progenitor, as shown in Figure 2 for the
clustered phylogenic clades and in Figure 4 for peptides that
share >86% of identity. It was common to observe that IFN-
ω molecules from one species are phylogenically closer to the
orthologs from other species of the same Family/Genus than
those from the same species (Figures 2, 4). For the mammalian
genus/species that have multiple genes of IFN-ω subtype, we
observed that IFN-ω peptides such as in bats, moles, shrews, and
elephants are formed into two major sub-clusters; however, it is
primarily only one sub-cluster (with one to several “outliers”)
such as in swine and bovine species (Figures 2, 4). In addition,
several clusters of IFN-ω peptides contain IFN-ω peptides from
animals of different Genus/Family, such as that of the ungulate-
mix (alpaca, camel, and bioson) and the RBH-mix (rhino, bat,
and horse) clusters (Figure 4, upper panel). In contrast to the
potential evolutionary progenitor shared in mammalian species,
IFN-ω genes undergo reduction or expansion independently
in each animal species, which are especially evident, such as
IFN-ω gene expansion in swine and bovine species (Figure 4,
bottom panel).
Constitutive and Induced Expression of
Porcine IFN Genes
Our previous expression analysis of porcine type I IFNs in
normal intestine, lymph nodes, and lung revealed that epithelial
and constitutive expression of unconventional IFNs (particularly
IFN-ε, -κ, -δ, and -ω) in contrast to IFN-α subtype that is prone
to an inductive expression during antiviral responses (9, 13).
Among IFN-ω subtype, IFN-ω1, -ω2, and -ω3 were expressed
higher than IFN-ω4 and –ω5 (Figure 5A). In response to the
viral infection, we demonstrated that PRRSV-infection induced
higher expression (5–10-fold than the control) of multiple
IFN subtypes/genes in the lungs from adult sows that had
been infected for 14 days. However, the induced expression of
IFNs was much weaker (<5-fold) and even suppressed by the
PRRSV infection in the fetus from the PRRSV-infected sows
and especially unresponsive in the alveolar macrophages infected
for 6 h in vitro (Figure 5B). Collectively, these findings show
that innate immune IFN expression is not restricted to antiviral
responses but is extensively involved in immune homeostatic
regulation in epithelial mucosa, where inflammation is restricted
for normal physiological functions (9, 13, 30–33).
Higher Acidic- and Thermal Stability of
Porcine IFN-ω Subtype
Compared with IFN-γ, two major physiochemical property of
type I IFN peptides are their tolerance in acidic solutions (pH
< 4.5), but less thermal stability in higher temperature (1,
20, 25). For comparative activity assays, we synthesized several
porcine IFN peptides using both a mammalian expression system
(HEK293F, Invitrogen) for authentic verification at small scale
(9, 13) and a yeast-expression system (Kingfisher Biotech) for
bulk production (24). Pertaining to antiviral activity compared
in several virus-cell systems (conducted both previously and in
this study), IFN peptides produced in both mammalian and
yeast system were very comparable and exerted very similar
antiviral activity (9, 24). We determined the acidic and thermal
stability of IFN-ω1 and IFN-ω5 peptides in comparison to IFN-
α1 peptide. As shown in Table 1, both IFN-α and IFN-ω peptides
had similar acidic stability after incubation with an acetic acid
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FIGURE 3 | Phylogenetic relationships of porcine IFN-ω genes (SsIFNW1-7)
and identified genomic polymorphisms (Ws). SsIFNW1-7 represent seven
original identifications of IFN-ω genes, of which they share <95% sequence
identity among each other. SsIFNW4L, 5L, 6L, and 7L are nearly identical
duplicates of SsIFNW4-7, respectively; they are further annotated from current
swine genome assembly (Sscorfa10.2). All genomic polymorphisms generally
have only one to several nucleotide mutations and are clustered with their
parental SsIFNW genes in the same branches. Note, more SsIFNW5
polymorphisms have been identified, and they exert diverse antiviral activity as
partly shown in Figure 9. The associated taxa clustered together in the
bootstrap test (1,000 replicates) are shown next to the branches. Evolutionary
analyses were conducted with MEGA6 (http://www.megasoftware.net/).
*Primary IFN-W5 sequence used for activity assay.
buffer at pH 2.0 for 24 h at 4◦C. Incubation of IFN peptides in
acidic buffer caused almost no loss in antiviral activity against
PRRSV infection in MARC-145 cells (Table 1). In contrast, high
temperatures at 42, 56, or 63◦C for 5 h removed all activity of the
IFN-α peptide; however, IFN-ω peptides showed better thermal
stability. IFN-ω1 retained most active after treated at 42◦C, IFN-
ω5 retained much activity even when treated at 56 or 63◦C for
5 h (Table 1). We also examined the acidic and thermal stability
using a more sensitive ISG-promoter reporter luciferase assay
and observed similar results as that of the antiviral assay (data
not shown) (13, 23). Hence, porcine IFN-ω peptides exert better
thermal stability but similar acidic stability compared to IFN-α
peptide (20, 25).
Anti-proliferative Activity in Cells From
Different Animal Species
Anti-proliferative activity underlies anti-tumor mechanism of
IFNs (4, 34). Compared with classical IFN-α1 and IFN-β, porcine
IFN-ω1 and -ω5 (at the concentrations > 0.02 ng/ml) displayed
higher antiproliferative activity in porcine monocytes. In porcine
epithelial cell lines from testes (ST) or kidney (PK-15), IFN-
ω5 but not IFN-ω1 exerted similar antiproliferative activity
as IFN-α1 and IFN-β at the tested concentrations (Figure 6,
top panel). Surprisingly, porcine IFN-ω1 and IFN-ω5 also
significantly suppressed the proliferation of mouse cell lines, but
actually showed stimulation of cell proliferation in both human
and monkey kidney cells (A549 and MARC-145). Collectively,
porcine IFN-ω subtype, in particular the high antiviral IFN-ω5
also exerted higher antiproliferative activity in all tested porcine
cells and mouse cells, but no activity in tested primate cells.
Induction of Interferon-Stimulated
Genes (ISGs)
Innate immune IFNs confer antiviral and immunomodulatory
roles through induction of hundreds of IFN stimulated genes
(ISGs), which are generally classified into robust or tunable
ISGs relative to their responsive intensity to IFN stimulation
(10, 35, 36). Whereas, most robust ISGs are involved in
antiviral responses, tunable ISGs are more broadly modulatory
for immune and developmental regulation (35, 36). To test the
differential potency of porcine IFN-ω in induction of ISGs,
we measured the expression of six typical ISGs (three robust
and three tunable) (10, 35, 36) in animal and human cells
treated with the overexpressed peptides (IFN-α1, IFN-β, IFN-
ω1, and IFN-ω5) for 24 h. The three robust ISGs are caspase 1,
phospholipid scramblase 1 (PLSCR1), and ubiquitin-like ISG15
(ISG15); and the three tunable ISGs include interleukin 11
(IL11), IFN-regulatory factor 1 (IRF1), and tumor necrosis
factor alpha receptor superfamily 10A (TNFRSF10A). Data show
that, IFN-ω1 and IFN-ω5 stimulated the robust ISGs (esp.
ISG15) to an extent similar to or higher than IFN-β and
IFN-α1, respectively, in porcine or non-porcine cells. However,
IFN-β and IFN-α1 are generally less active than IFN-ω5 in
stimulation of the three tunable ISGs in the cells of non-
porcine origin (Figure 7). Interferon-regulatory factor (IRF) 3,
IRF7 and Myxovirus resistance protein 1 (Mx1) genes are other
representative ISGs that play key roles in IFN auto-regulation
(such as IRF3 and IRF7 in further potentiation of IFN-β and
IFN-α production in macrophages and pDCs, respectively) and
in anti-Myxovirus (such as influenza) activity (10, 35, 36). Using
a promoter-reporter based bioassay (13, 23), we analyzed the
stimulation of IRF3, IRF7, and Mx1 expression by treatment
with different concentration of IFN-α1, IFN-ω1, and IFN-ω5.
Porcine IFN-ωs, particularly IFN-ω5 exerted higher activity in
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FIGURE 4 | Pairwise identity (%) plots among protein sequences of IFN-ω orthologs. Comparison and plot drawing were performed using a SDT program. IFN-ω
molecules from individual Order or Genus might share a common progenitor, as also shown in the Figure 2 for the clustered phylogenic clades that share >86% of
identity. It was also common to observe that IFN-ω molecule from a species is phylogenically closer to the orthologs from other species of the same Family/Genus
than those from the same species. For the mammalian genus/species that have multiple genes of IFN-ω subtype, we observed that IFN-ω peptides such as in bats,
moles, shrews and elephants are formed into two major sub-clusters (Upper); however, it is primarily only one sub-cluster (with one to several “outliers,” labeled with
red arrow or brackets) such as in swine and bovine species (Bottom). In addition, several clusters of IFN-ω peptides contain IFN-ω peptides from animals of different
Genus/Family, such as that of the ungulate-mix (Alpaca, Camel, and Bioson) and the RBH-mix (Rhino, Bat, and Horse) clusters (Upper). RBH: R. Rhino, B. Bat, and
H, horse; and other Species name abbreviations are first letters from the Latin names listed in the Supplemental Excel Sheet according to NCBI Taxonomy at http://
www.ncbi.nlm.nih.gov/Taxonomy (2, 8–10).
stimulation of IRF7 and Mx1 expression, but are similar to IFN-
α1 for the effect on IRF3 promoter (Figure 8). In summary,
porcine IFN-ω subtypes, especially the highly antiviral IFN-ω5,
potentially signal ISG expression to exert antiviral immunity
differently from the classical IFN-α1 and IFN-β subtypes in both
porcine and human cells (13, 23).
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FIGURE 5 | (A) Relative gene expression of porcine type I IFNs in the intestine, mesenteric lymph nodes, and lung from normal 5-week-old pigs. Real time RT-PCR
assays were conducted as in Manry et al. (7), basal expression of IFN genes was normalized against Ct values of a housekeeping gene (GAPDH) and presented as
relative expression index. Compared with the genes of IFN-α subtype (gene symbol IFNA, and so on) that are mostly inductive, unconventional porcine type I IFN
genes including IFNWs show much higher constitutive expression in mucosal tissues and lymph nodes. Data, n = 3 PCR repeats of tissue samples from 3 to 5 pigs.
(B) Sub-optimal stimulation of porcine type I IFNs in PRRSV-exposed fetal lungs and alveolar macrophages (MΦ). Lungs of fetuses and pregnant sows infected with
PRRSV at the 90th of the gestation day, and porcine alveolar MΦ infected in vitro with PRRSV for 6 h were evaluated for mRNA expression of IFNs. Data, n = 3 PCR
repeats of tissue samples from 3 samples (9, 10, 13, 24).
Broad and Higher Antiviral Activity
We have compared the antiviral activity of 20 porcine IFN
peptides family-wide. Compared with typical subtypes of porcine
type I and III IFNs including IFN-α and -β, IFN-ω exerted most
broad antiviral activity. Using VSV and PRRSV, we previously
reported that in porcine and monkey cells, most IFN-α peptides
showed high antiviral activity on average (9, 13). Interestingly,
IFN-ω peptides exert broad antiviral activity including IFN-
ω1 to IFN-ω2 having generally low to mid antiviral activity,
and IFN-ω5 (particularly, polymorphic mutant of IFNω5-2 in
Figure 3) exerting the highest antiviral activity. Other subtypes,
including IFN-β and most IFN-δ induced much lower antiviral
activity (9, 13). In Figure 9, we further compared antiviral activity
of porcine IFN-α1, IFN-ω1, and IFN-ω5 against PRRSV (a
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FIGURE 6 | Interferon antiproliferative activity assay. Cellular viability was assessed by trypan blue dye exclusion (23, 24). Five-hundred cells in 100 µl volume were
added to each well of a flat-bottom 96-well plate in triplicate. Cells were treated with or without IFN peptides at indicated concentrations and incubated at 37◦C for
72 h. Cell growth was determined by a MTS-salt assay (Promega, Madison, WI). Briefly, 20 µl of MTS reagent was added to each well and the plate incubated for
2–4 h at 37◦C. Following color development, absorbance was measured at 490 nm on a with a SpectraMax i3 (Molecular Devices) spectrometer. Data, mean ± SE,
n = 6, *p < 0.05 compared to the mock-treated control.
TABLE 1 | Higher acidic- and heat-stability of porcine IFN-ω subtype.
IFN concentrations (µg/ml) reduced cell loss by 50% according
to Reed-Muench method
Untreated pH = 2.0 42◦C 56◦C 63◦C
IFN-α1 1.1 × 10−3 1.1 × 10−3 - - N
IFN-ω1 1.1 × 10−3 1.1 × 10−3 2.0 × 10−2* - -
IFN-ω5 1.1 × 10−5 1.1 × 10−5 1.1 × 10−5 1.1 × 10−3* 1.1 × 10−2*
N, no test; -, no antiviral activity with the tested IFN concentrations as high as 0.2 µg/ml
after the treatments. *p < 0.05; compared to untreated control.
type II P129 strain) and several strains of influenza A virus
(pH1N1,WSN, and K07 strain) in corresponding porcine, mouse
and primate cells that are susceptible to the indicated virus
infection. IFN-α1 generally had an activity at 103-104 U/µg/ml
against PRRSV in porcine and MARC-145 cells, but had little
activity against influenza viruses in human and mouse cells. In
contrast, IFN-ω1 and particularly IFN-ω5, were broadly and
highly active against both PRRSV and influenza viruses in cells
from the four mammalian species. In all eight types of virus-cell
infection systems, IFN-ω5 exerted the highest antiviral activity
(100–1,000-fold higher than IFN-α1) for PRRSV and influenza
viruses (Figure 9).
The “Outliers” of the Unconventional
IFN Subtypes
In addition to the major clusters of the unconventional IFN
subtypes in livestock, we also detected some “outliers” per
molecular signatures. For example, porcine IFN-δ1, -δ2, and -ω2,
as well as bovine IFN-ω4 (Bb), -ω6 (Bt), -ω14 (Bb), -ω22 (Bt)
show less sequence identity (<80%) overall to other members of
the same IFN subtypes (Figures 2, 4). As thesemembers generally
showed little antiviral activity in all our tests (9, 13, 23), we
also detected that these “outliers” of the unconventional IFN
subtypes generally do not contain signal peptides for extracellular
secretion of the mature IFN peptides (Figure 10) (10, 37). This
indicates that these “outliers” may represent a group of IFNs
that mediate IFN responses via a newly identified intracellular
pathway (10, 37), or a non-canonical IFN signaling pathway to
mediate some unknown functions (10, 37–39).
DISCUSSION
Based on fragmentary information, previous studies on IFN
molecular evolution posited a general linear increase of IFN-
coding genes during vertebrate evolution and a dramatic
acceleration after the emergence of intronless IFN genes,
presumably in reptiles (12, 40). We have examined IFN genes
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FIGURE 7 | Differential induction of IFN-stimulated genes (ISGs) by porcine IFN peptides in porcine (MΦs), monkey (MARC-145), human (A549), and mouse (NIH3T3)
cells. Cells at 80% confluence were treated with overexpressed IFN peptides (20 ng/ml) for 24 h. Gene expression was analyzed using a SYBR Green-based real-time
RT-PCR assay. Total RNA (100 ng) was used in each 20 µl of PCR reaction. Ct values of the genes were normalized against Ct values of a housekeeping gene
(beta-actin) amplified from the same RNA samples to obtain 2−1Ct, which reflects the expression of each ISG relative to beta-actin and were further normalized for
fold changes to the control (mock). CASPAS1, caspase 1; IL11, interleukin 11; IRF1, IFN-regulatory factor 1; ISG15, ubiquitin-like IFN stimulated gene 15; PLSCR1,
phospholipid scramblase 1; TNFRSF10A, tumor necrosis factor alpha receptor superfamily 10A (10, 24). Data are means ± SE; n = 3 replicates of 2–3 independent
assays, a, b, and c: p < 0.001, 0.01, and 0.05, respectively, compared to control.
FIGURE 8 | IFN comparative activity bioassay in MARC-145 cells that stably transformed with an IFN-regulatory factor (IRF)3-, IRF7-, or a myxovirus resistance gene
1 (Mx1)-promoter driven luciferase reporter system. MARC-145 cells that were transformed with the promoter-reporter constructs were treated with IFN peptides at
indicated concentrations for 24 h, lysed with Glo lysis buffer and quantified by Steady-Glo® Luciferase Assay System (Promega) (13, 24). Data are means ± SE; n =
3; *p < 0.05 relative to the control.
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FIGURE 9 | Porcine IFN-ω peptides exert broad and high antiviral activity in porcine, monkey, human, and mouse cells. (A) A series of porcine IFN peptides were
overexpressed using a mammalian cell expression system (HEK193F, Invitrogen, Carlsbad, CA). IFN peptides were collected and partially purified using two
Centricon® centrifugal filters (10 and 50 k NMWL, Millipore, Billerica, MA). Concentrated IFN-peptides were subjected to gel electrophoresis and stained with a
bio-safe Coomassie Blue G-250 solution. Shown are peptide bands of most IFN-α/β subtypes, IFN-ω1, and IFN-ω5. Note that the bands of IFN-α6, IFN-α9, and IFN-β
are smeared and have apparent molecular weights higher than expected values (∼20 kDa), which might reflect posttranslational modification such as N-glycosylation
(13, 23). (B) Porcine IFN-ω peptides exert broad and high antiviral activity against PRRSV and influenza A virus in cells from pigs, monkeys, humans, and mice. The
antiviral activity of IFN peptides was titrated as described (7), except viruses were quantified using fluorescence-labeling (PRRSV-DsRed and FITC-immunostaining for
influenza A nucleoprotein) in the susceptible cells of monkey MARC-145, porcine macrophages (MΦs) and PK-15, human A549, and mouse Mode-K and NIH3T3
(13, 24). A PRRSV-P129 strain, and three influenza strains, pH1N1, WSN, and KS07 were used. a,b; p < 0.001, 0.01 to IFN-α1, respectively. Data are means ±
SE; n = 5.
across the genome sequences of more than 110 animal species,
and specifically characterized the emergence and expansion
of intronless IFNs in amphibians (Figure 1) (10, 12). Further
subtype-diversification of intronless type I IFNs in ungulates,
especially in livestock species including pigs and cattle, comprises
other evolutionary surges of IFN gene expansions (8, 9). Swine
and bovine species thus contain a large gene number of IFNs
including several multi-gene IFN subtypes such as IFN-δ, -ω,
and –τ , which represent an apex of IFN gene expansion in
mammalian species (1–9). In contrast to the surges of IFN
genes in amphibians, chickens, bats, mice, and especially in pigs
and cattle, we also observed intriguing reduction of IFN genes
in wild birds and underground rodent species (such as naked
mole-rats) (Figure 1). These findings support a species/lineage-
independent “bouncing” model of IFN molecular evolution and
subtype-diversification across vertebrates (2, 10, 12, 40). The
porcine (and bovine) IFN complex thus symbolizes a significant
surge in IFN molecular evolution, which is distinguished by
the expansion of multi-gene IFN subtypes beyond the classical
IFN-α subtype (Figure 1) (8, 9). As the emergence and rapid
expansion of intronless IFNs in amphibians were ascribed to
cope with dramatic environmental changes during terrestrial
adaption (10, 12), we interpret that most species-dependent
evolution surges or retreats in IFN gene numbers are related
to increased or decreased chances in pathogenic exposure
(particularly intracellular ones like viruses) in their ambient
habitats (1–7). The obvious IFN gene expansion such as in
chickens, mice, pigs and cattle are likely relevant to their
“domestic” process with humans, which are implicated by the
increasing IFN gene numbers along three bovine species, i.e., wild
yak (Bos mutus), zebu cattle (Bos indicus), and cows (Bos taurus)
(Figure 1) (2, 41).
Although amphibians such as Xenopus have diversified 20–
30 of intronless IFN molecules, these amphibian IFNs seem to
have evolved independently and share little molecular phylogeny
(<45%) to IFN subtypes in mammals (2, 10, 12). The early
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FIGURE 10 | Signal peptides of swine and bovine IFN peptides were examined using PrediSi (http://www.predisi.de) to determine the secretory potency of relevant
IFN mature peptides, indicating the evolution of intracellular IFNs (indicated by arrows, signal peptide prediction score 0–0.5) in each subgroup, particularly of
unconventional IFN subtypes such as IFN-δ and IFN-ω subtypes that undergoing multi-gene expansion such as in pigs and cattle (2, 9).
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IFN-ω-like genes (also potentially to be progenitors of IFN-β or
–κ) were determined in reptiles and clearly in some avian species
(2). Similar to the diversification of other unconventional IFN
subtypes, IFN-ω subtype is common in almost all mammalian
species and rapidly evolved into multi-gene IFN subtype in
ungulate, bats and some carnivore species, with the exception
of rodents. Human and other primate species only have one
IFN-ω molecule in each species (Figures 1, 2) (2). Human
IFN-ω was demonstrated to be a leukocyte interferon, which
had antiviral, anti-proliferation, and antitumor activities that
are similar (but more broadly active) to those of IFN-α
(20). Previous studies in feline IFN-ω explored them as a
therapeutic option for some autoimmune diseases or retroviral
infections in humans and other animals. Some recombinant
feline IFN-ω peptides have been licensed in several countries
for treating canine parvovirus, feline leukemia virus, and
feline immunodeficiency virus infections (18, 42), indicating
the broad antiviral potency and therapeutic potentials of this
unconventional IFN subtype (13, 19, 20). Others and we have
genome-wide analyzed the superior IFN complex in ungulate
species especially in pigs and cattle (8, 9), indicating that these
livestock species contain the IFN complex including IFN-ω
subtype which may conceive distinct IFN molecules having
higher antiviral or other biological activity. In addition to
these genetically fixed IFN alleles, we have also identified many
polymorphic isoforms across the porcine type I IFN gene
family (14, 29), of which some differ by only one or a few
residues but exert dramatic antiviral alterations, such as by
different IFN-ω variants (Figure 3) (14, 29). Indeed, such as
those among seven porcine IFN-ω5 isoforms, we determined
a polymorphism (IFN-ω5-2, Figure 3) that has much higher
antiviral activity broadly in all our analyses including seven
different virus-cell systems (Figure 9) (14, 19). This correlates
with the seminal discovery of structure-activity relationship of
IFN site-mutants by Thomas et al. (29) and indicates the efficacy
of “fine-tuning” approaches in optimization of IFN biology
activity (29, 43).
Both species-specific and cross-species activities of IFNs
have been reported previously and observed in our studies (2,
18, 20, 42). Theoretically, IFN activity is determined by the
compatibility of an IFN ligand with cell IFN receptors. Due
to the evolution of both IFNs and IFN receptors across the
vertebrates, typical IFN subtypes such as IFN-α/β show more
or less cross-species antiviral activity within each vertebrate
groups such as fish, amphibians, reptiles, birds, and mammals.
However, the cross-species activity is rare between species of two
groups (unpublished data). In contrast, cross-species activity of
species-specific IFN subtypes (such as IFN-δ/τ /ξ in pigs, cattle,
and mice, respectively) should be limited due to phylogenic
distinctness. Whereby, mammalian IFN-ω subtype seems to
retain at least antiviral activity within most mammalian species
as demonstrated with the single human IFN-ω as well as multiple
IFN-ω peptides in cats and pigs (2, 18, 20, 42). In summary, both
species-specific and cross-species IFN activity are two sides of the
same coin, which reflects the variation and conservation during
IFN evolution (2, 4, 7, 20).
Both phylogenic and cluster analyses of cross-species IFN-ω
molecules at protein levels imply that mammalian IFN-ω subtype
was diverted from a common IFN ancestor gene during the
evolution of reptiles or birds (2). Even though mammalian IFN-
ω subtype is similar to its IFN-α orthologs with regard to the
antiviral or other biological activity, we show that its molecular
origin may be closer to other common IFN subtypes such
as IFN-ε/κ. After subtype-ramification, IFN-ω seems further
diversify independently in different mammalian Family/Genus.
However, cross-species analysis of IFN-ω sequence similarity at
the protein level demonstrated that there are two general IFN-ω
subgroups existing in such as moles, bats, shrews, and elephants,
indicating IFN-ω molecules in these mammalian species might
be derived from two close progenitors or further ramified along
two directions (2, 41). In contrast, IFN-ω molecules in pigs and
cattle were generally clustered into one big cluster with several
outliers presumably derived from a recent gene recombination
event that may be catalyzed by some genetic repetitive elements
as demonstrated in previous studies (Figure 4) (2, 8–10).
Although human IFN-ω was previously determined as a
leukocyte cytokine (20), our expression assays indicate that
the multiple genes of porcine IFN-ω subtype are differentially
expressed in different tissues/cells, and that their expression
could be in either constitutive or an induced manner by a
viral infection. In general, the expression patterns of porcine
IFN-ω genes liken to unconventional IFN subtypes such as
IFN-ε/κ/δ than the IFN-α subtype in the constitutive situation
(Figure 5A) (9, 13); however, the porcine IFN-ω genes showed
their own pattern of induced expression during viral infection.
Notwithstanding, the fact that more gene-specific assays to
examine their diverse expression at both RNA and protein levels
are needed. The current data imply the necessity for gene-specific
(at least subtype-specific) expression and activity analysis for
IFN-ω subtype, especially in the animal species such as pigs,
bats, and cattle, where they show multi-gene expansion of IFN-ω
subtype (13, 24).
Compared with the classical IFN-α subtype, the antiviral
activity of porcine IFN-ω peptides (especially IFN IFN-ω5)
showed similar acidic stability but higher resistance to heat
treatments (Table 1). Increased thermostability is correlated to
the increase in the number of hydrogen bonds and in polar
surface area fraction of a protein (44). We interpret that the
thermal stability of some IFN-ω peptides may reflect their
property in tertiary structure, which in turn may contribute to
the broader and higher antiviral activity by the affinity of the
IFN ligand-receptor interaction (29). Currently, there are few, if
any, studies comparing the affinity difference between IFN-ω and
IFN-α/β to the common IFN receptors of IFNAR1/2 (29).
In the canonical IFN signaling, IFNs engage type-specific IFN
receptors (such as IFNAR1/2 or IFNLR1/IL10RB for type I or
III IFNs, respectively) on the cytoplasmic membrane to induce
expression of hundreds of ISGs that play roles in restricting
viruses and regulating other biological responses (4, 38). To
compare the efficacy of IFN-ω in induction of ISGs with IFN-α/β,
we detected the expression of six ISGs representing both robust
antiviral genes and tunable immunomodulatory genes across
porcine, human, monkey and mouse cells (35, 41). Porcine IFN-
ω subtype, particularly IFN-ω5, generally showed higher activity
in induction of some robust genes and most tunable genes, as
well as being broader efficacy in human, monkey, and mouse
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cells. We hypothesize that this differential activity in induction
of ISGs contributes to the superior antiviral activity of the IFN-
ω5 peptide; however, which ISGs play a critical role will require
future mechanistic studies using the knock-out/-in models (35,
41). In contrast to the pro-inflammatory role of IFN-γ in
immune regulation, recent studies demonstrated primary anti-
inflammatory activity as well as immune-homeostatic regulation
of innate immune IFNs (3, 4). In this regard, we and others have
shown that unconventional IFNs, such as porcine IFN-ω and –δ
subtypes, may have evolved to be subject for anti-inflammatory
regulation during antiviral response, particularly for those IFN
subtypes that show constitutive and epithelial expression (1–7).
The majority of IFN studies have concentrated on the induced
expression of classical antiviral IFN-α/β responding to viral
infection or treatments with viral mimics (1–7). Recent studies
highlighted the tissue-specific expression of unconventional IFN
subtypes such as IFN-λ in gut epithelia, IFN-κ in skin, and
IFN-ε/τ in reproductive tract (5, 15, 31, 32). Thus, more gene-
specific expression analyses need to be developed to determine
potential tissue- or even cell-specific expression of the expanding
unconventional IFN subtypes (such as IFN-δ/τ /ω in pigs and
cattle) to elucidate functional characterization of these less-
studied IFN subtypes. In addition, recent studies of the multi-
functional property of unconventional IFNs also propose that
IFNs can mediate immune or other physiological responses via
non-canonical signaling pathways including that by intracellular
IFN-signaling independent of membrane-bound IFNAR and
through MAPK- and PI3K-mediated pathways independent to
STAT transcription factors (4, 23, 37–41). Currently, direct
evidence to determine if some IFN-ω may adopt these non-
canonical signaling pathways to mediate subtype-specific IFN
responses is lacking; however, our discovery of their differential
biological responses in antiviral, anti-proliferation, and ISG
induction, especially the lack of a signal peptide for extracellular
secretion, all imply this possibility (4, 23, 37–41).
In summary, genome-wide annotation of the IFN complex
across more than 110 representative species of vertebrates
allows us to extensively re-examine the IFN evolutionary model
(2, 10, 40), which serves as a critical molecular marker for
immune evolution simultaneous to emergence of adaptive
immunity in vertebrates (45). Our extensive phylogenic analyses
refined several “turning-points” in IFN evolution, including
the emergence and expansion of intronless IFN genes in
amphibians as well as further IFN-subtype diversification
surge in bats and especially in ungulate species (2, 8–12).
Furthermore, we emphasize the necessity for molecular and
functional characterization of unconventional IFN subtypes
using several animal models, which show significant IFN
expansion thus providing molecular resource for identifying
and optimizing “super” IFNs for therapeutic application in
either antiviral or immunomodulatory directions (3, 18, 19). We
propose using the porcine IFN model, that unconventional IFN
subtypes such as IFN-ω are promising for developing IFN-based
antivirals that exert antiviral activity superior to classical IFN-
α/β subtypes, which stresses the multi-functional property of IFN
cytokines beyond the several well-studied subtypes and calls for
mechanistic studies of the non-canonical IFN signaling pathways
(4, 37–41).
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